Original Source(s)
Related Content
FDA Approves Melanoma BRAF Companion Test
The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.
August 10, 2026
-
1 min
Your Genes May Shape Tumor Evolution
Mouse study links inherited genetics to driver mutation selection, genome stability, and tumor evolution
August 19, 2026
-
3 min
Cyclospora Alert Spurs US Testing Focus
CDC links multistate outbreak to recalled iceberg lettuce, highlighting the need for targeted laboratory testing
August 13, 2026
-
2 min